Company intelligence / Profile preview

Cytopeutics

Cyberjaya, Selangor, Malaysiacytopeutics.com ↗

Ownership: Private
Employees: ~30
Development stage: Phase 2

Overview

Cytopeutics has completed multiple major clinical trials demonstrating safety and efficacy of its MSC therapies in stroke, heart failure, arthritis/inflammation and diabetes complications. The company holds US patents for cell-based treatments targeting stroke and diabetes. Some programs are provisionally listed by Malaysia’s National Pharmaceutical Regulatory Agency (NPRA). The company was recognized globally as a leading biotech innovator.

Therapeutic areas: CardiovascularRheumatologyEndocrinologyImmunologyNeurology
Modalities: Mesenchymal stem cells (MSC)cell therapymulticellular immunotherapy (including cytokine-induced killer cells and polarized M2 macrophages)
Industry: Biotech

Drug pipeline

5 assets

umbilical cord tissue mesenchymal stem cells

4 more assets in the full pipeline.

Request access →

Partnerships

Siris BioSciences co-developer on Neuroncell‑EX programcollaborations with renowned universities for research/clinical trials

Beyond the preview

Go deeper on Cytopeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytopeutics.

Explore the full profile